Ptc Therapeutics (PTCT) Other Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $22.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 5.74% year-over-year to $22.6 million; the TTM figure through Mar 2026 stood at $22.6 million (up 5.74% YoY), while the FY2025 annual figure was $18.3 million, down 11.6% from the prior year.
• Other Non-Current Assets was $22.6 million for Q1 2026 at Ptc Therapeutics, up from $18.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $60.3 million in Q2 2022 to a low of $18.3 million in Q4 2025.
• Historically, Other Non-Current Assets has averaged $33.0 million across 5 years, with a median of $25.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets increased 7.85% in 2023, then tumbled 48.73% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $48.6 million in 2022, then slipped by 25.39% to $36.2 million in 2023, then plunged by 42.88% to $20.7 million in 2024, then retreated by 11.6% to $18.3 million in 2025, then rose by 23.74% to $22.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $22.6 million (Q1 2026), $18.3 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.